11 companies

AddLife

Market Cap: SEK 18.9b

Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.

ALIF B

SEK 157.80

7D

10.7%

1Y

-19.8%

Bonesupport Holding

Market Cap: SEK 14.8b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BONEX

SEK 230.80

7D

7.6%

1Y

-12.8%

Swedencare

Market Cap: SEK 4.3b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 27.05

7D

2.1%

1Y

-38.5%

Devyser Diagnostics

Market Cap: SEK 1.6b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

DVYSR

SEK 92.80

7D

-2.5%

1Y

-18.0%

Cinclus Pharma Holding

Market Cap: SEK 573.3m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

New

CINPHA

SEK 12.02

7D

-0.3%

1Y

-32.3%

Mendus

Market Cap: SEK 312.9m

A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.

IMMU

SEK 5.18

7D

-0.4%

1Y

-0.4%

Promimic

Market Cap: SEK 207.8m

Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.

PRO

SEK 10.50

7D

-13.2%

1Y

-43.2%

Diamyd Medical

Market Cap: SEK 172.7m

Develops precision medicine therapies for the treatment of autoimmune diabetes.

DMYD B

SEK 1.13

7D

-0.2%

1Y

-88.9%

IDL Diagnostics

Market Cap: SEK 115.0m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

New

IDLDX

SEK 0.49

7D

0.8%

1Y

-9.3%

Alzinova

Market Cap: SEK 71.2m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

ALZ

SEK 0.44

7D

0.3%

1Y

-72.7%

PharmaLundensis

Market Cap: SEK 15.3m

PharmaLundensis AB operates as a pharmaceutical company.

PHAL

SEK 0.36

7D

0%

1Y

-44.6%